The use of a prospective audit proforma to improve door-to-mask times for acute exacerbations chronic obstructive pulmonary disease (COPD) requiring non-invasive ventilation (NIV)
- PMID: 24945887
- DOI: 10.3109/15412555.2014.898044
The use of a prospective audit proforma to improve door-to-mask times for acute exacerbations chronic obstructive pulmonary disease (COPD) requiring non-invasive ventilation (NIV)
Abstract
Non-invasive ventilation (NIV) is an evidence based management of acidotic, hypercapnic exacerbations of COPD. Previous national and international audits of clinical practice have shown variation against guideline standards with significant delays in initiating NIV. We aimed to map the clinical pathway to better understand delays and reduce the door-to-NIV time to less than 3 hours for all patients with acidotic, hypercapnic exacerbations of COPD requiring this intervention, by mandating the use of a guideline based educational management proforma.The proforma was introduced at 7 acute hospitals in North London and Essex and initiated at admission of the patient. It was used to record the clinical pathway and patient outcomes until the point of discharge or death. Data for 138 patients were collected. 48% of patients commenced NIV within 3 hours with no reduction in door-to-mask time during the study period. Delays in starting NIV were due to: time taken for review by the medical team (101 minutes) and time taken for NIV to be started once a decision had been made (49 minutes). There were significant differences in door-to-NIV decision and mask times between differing respiratory on-call systems, p < 0.05). The introduction of the proforma had no effect on door-to-mask times over the study period. Main reasons for delay were related to timely access to medical staff and to NIV equipment; however, a marked variation in practice within these hospitals was been noted, with a 9-5 respiratory on-call system associated with shorter NIV initiation times.
Keywords: chronic obstructive pulmonary disease; exacerbation; hypercapnic respiratory failure; non-invasive ventilation.
Similar articles
-
Open-mouthpiece ventilation versus nasal mask ventilation in subjects with COPD exacerbation and mild to moderate acidosis: a randomized trial.Respir Care. 2014 Dec;59(12):1825-31. doi: 10.4187/respcare.03009. Epub 2014 Aug 19. Respir Care. 2014. PMID: 25140033 Clinical Trial.
-
Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations.Thorax. 2011 Jan;66(1):43-8. doi: 10.1136/thx.2010.153114. Epub 2010 Nov 12. Thorax. 2011. PMID: 21075776
-
Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study.Thorax. 2014 Sep;69(9):826-34. doi: 10.1136/thoraxjnl-2014-205126. Epub 2014 Apr 29. Thorax. 2014. PMID: 24781217 Clinical Trial.
-
Current opinions on non-invasive ventilation as a treatment for chronic obstructive pulmonary disease.Curr Opin Pulm Med. 2013 Nov;19(6):626-30. doi: 10.1097/MCP.0b013e3283659e4c. Curr Opin Pulm Med. 2013. PMID: 24060980 Review.
-
Non-invasive ventilation in chronic obstructive pulmonary disease.J Physiol Pharmacol. 2004 Sep;55 Suppl 3:115-9. J Physiol Pharmacol. 2004. PMID: 15611602 Review.
Cited by
-
Time to NIV and mortality in AECOPD hospital admissions: an observational study into real world insights from National COPD Audits.BMJ Open Respir Res. 2019 Aug 5;6(1):e000444. doi: 10.1136/bmjresp-2019-000444. eCollection 2019. BMJ Open Respir Res. 2019. PMID: 31423314 Free PMC article.
-
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40585423 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous